Depression: all 8,240 studies
Page 78 of 83. Open to participants first (1,641), then studies with results posted, then the rest; newest registration first within each.
- Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With DepressionCompletedNCT00487500Phase 4
- Combination Therapy in Patients With DepressionCompletedNCT00485862Phase 4
- Yoga in Unipolar and Bipolar DisordersCompletedNCT00482482Not applicable
- A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and DepressionCompletedNCT00481026Not applicable
- Randomized Controlled Trial of the Effectiveness of Group Treatment With War-Exposed Bosnian AdolescentsCompletedNCT00480480Not applicable
- Screening Questionnaire for DepressionStatus unknownNCT00480233
- Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older AdultsCompletedNCT00480207Phase 2/3
- Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in ChinaCompletedNCT00478829
- Effects of Chromium Picolinate on Food IntakeCompletedNCT00477854Not applicable
- Lamotrigine Alone Compared to Lamotrigine Plus Antidepressant for the Treatment of Bipolar II DepressionCompletedNCT00475137Phase 2
- Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy SubjectsTerminatedNCT00470925Phase 1
- Transcranial Magnetic Stimulation for Bipolar DepressionWithdrawnNCT00470639Phase 1/2
- Transcranial Magnetic Stimulation: Treatment Trial for Depressed AdolescentsTerminatedNCT00470028Phase 1/2
- Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00467402Phase 3
- Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance TreatmentTerminatedNCT00464191Phase 4
- A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive DisorderStatus unknownNCT00464048Not applicable
- A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)CompletedNCT00463242Phase 3
- Reducing Health Risk Behavior and Improving Health in Adolescents With DepressionCompletedNCT00461539Phase 1/2
- Attachment Security as Mediator and Moderator of Outcome in Major DepressionCompletedNCT00461279Not applicable
- Evaluation of the Deep TMS H-Coil in the Treatment of Major Depression- Augmentation of Antidepressant MedicationCompletedNCT00460902Phase 1/2
- Depression and Interleukin-6 Production in Patients With Ovarian Epithelial CancerWithdrawnNCT00460200
- PEARL Intervention to Reduce Depression Among Adults With EpilepsyStatus unknownNCT00459329Not applicable
- Prevention of Mood Disorders by Folic Acid SupplementationCompletedNCT00459264Not applicable
- Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and ManiaCompletedNCT00457054Phase 4
- Wellbutrin XL Effects on SSRIs Induced ChangesCompletedNCT00456820Phase 4
- Serotonin Transporter Genetic Variation and Amygdalar Activation Correlates of Antidepressant ResponseCompletedNCT00456430Phase 4
- Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive DisorderCompletedNCT00452595Phase 3
- St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid AnxietyCompletedNCT00451516Phase 2
- The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive DisorderWithdrawnNCT00451490Not applicable
- A Efficacy Study of PRX-00023 in Patients With Major Depressive DisorderCompletedNCT00448292Phase 2
- A Study Of New Medicine (GSK 372475) For The Treatment Of DepressionCompletedNCT00448058Phase 2
- Safety and Antidepressant Effects of Rellidep in Major Depressive DisorderCompletedNCT00446719Phase 2/3
- Evaluating the Benefits and Affordability of a Program to Improve the Care of Common Mental Disorders in Primary CareCompletedNCT00446407Not applicable
- Treatment of Depressed Adolescents With Physical IllnessCompletedNCT00446238Not applicable
- Evaluation of Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major DepressionCompletedNCT00445237Phase 1
- Evaluation of the H-Coil Transcranial Magnetic Stimulation (TMS) Device in the Treatment of Bipolar DepressionCompletedNCT00444938Phase 1
- Diagnosis of Depression Among AdolescentsCompletedNCT00443742
- Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderStatus unknownNCT00442481Phase 4
- Morbidity and Mortality Among Dialysis Patients After Treatment for DepressionStatus unknownNCT00442429
- Treatment Resistant Depression and Obstructive Sleep Apnea, Effect of Continuous Positive Airway Pressure (CPAP)Status unknownNCT00441636Not applicable
- Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)CompletedNCT00440427Phase 1
- Telemedicine-Based Collaborative Care to Reduce Rural DisparitiesCompletedNCT00439452Not applicable
- Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing DisordersCompletedNCT00438685Phase 1
- rEEG Guided Pharmacotherapy of Subjects With Depression Treatment FailureCompletedNCT00437827Not applicable
- Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed PatientsCompletedNCT00437385Phase 1
- Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent MothersCompletedNCT00436150Not applicable
- rTMS in the Treatment of Bipolar DepressionCompletedNCT00436020Not applicable
- A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and InsomniaCompletedNCT00435279Phase 3
- Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderCompletedNCT00432614Phase 3
- Screening and Treatment of Depression in the CommunityCompletedNCT00430404Phase 4
- Hormonal Levels in Men With Major Depressive DisorderWithdrawnNCT00429689
- A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With DepressionCompletedNCT00429260Phase 3
- Prozac Treatment of Major Depression: Discontinuation StudyCompletedNCT00427128Phase 4
- Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open StudyStatus unknownNCT00426946Phase 4
- Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00424203Phase 2
- Galantamine Augmentation of Escitalopram for Treatment of DepressionTerminatedNCT00423969Phase 4
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.CompletedNCT00421369Not applicable
- An Intervention Study to Increase Physical Activity and Maternal Well-being During PregnancyCompletedNCT00419211Early Phase 1
- Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health TreatmentCompletedNCT00419029Not applicable
- PACEPro - Mood Management PilotCompletedNCT00416221Not applicable
- An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive DisorderCompletedNCT00415142Phase 3
- Using Learning Teams for Reflective Adaptation for Diabetes and DepressionCompletedNCT00414986Not applicable
- Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)CompletedNCT00413023Phase 2
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411242Phase 3
- Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNCT00411099Phase 3
- Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.Status unknownNCT00408304Phase 2
- D-cycloserine for Major Depressive DisorderCompletedNCT00408031Phase 2
- Study for Evaluating Different Methods of Measuring Depression Treatment ResponseCompletedNCT00406952Not applicable
- Depression Screening in Patients With Lung CancerCompletedNCT00404365Not applicable
- Use of Omega-3 Fatty Acids for Perinatal DepressionCompletedNCT00402389Phase 2
- Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or SuicideTerminatedNCT00400088Phase 3
- Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic TherapyCompletedNCT00399776
- Antidepressant Safety in Kids StudyCompletedNCT00395213
- Study of Whether Educational Visits to Primary Care Professionals Improves the Quality of Care They Provide.CompletedNCT00393536Not applicable
- Somatosensory Processing in DepressionWithdrawnNCT00386893Phase 4
- Outcome Following Antidepressant Treatment on Possible Endo-Phenotypes for Major DepressionCompletedNCT00386841Phase 4
- A Study on Improving Detection and Management of Suicide Risk Among Depressed Patients in Primary CareStatus unknownNCT00386711Phase 1
- Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive DisorderCompletedNCT00385437Phase 2
- Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)CompletedNCT00385307Phase 3
- Study of Home-Based Exercise to Alleviate Postpartum DepressionCompletedNCT00384943Not applicable
- Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed PatientsCompletedNCT00384436Phase 4
- Clinical Pharmacogenomics of Antidepressant ResponseCompletedNCT00384020
- Supportive Expressive Therapy for Depressed and Anxious AdolescentsCompletedNCT00381979Not applicable
- Healthy Outcomes of Pregnancy EducationStatus unknownNCT00381823Phase 2
- Effects of Interpersonal Psychotherapy on Depression During and After PregnancyCompletedNCT00380419Not applicable
- Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive DisorderTerminatedNCT00380042Phase 1
- Comparison of Thiopental and Propofol as Anaesteticum During ECTStatus unknownNCT00379886Not applicable
- Descriptive Study of Pain, Anxiety and DepressionCompletedNCT00378274
- Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant MedicationCompletedNCT00375843Phase 4
- Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in WomenCompletedNCT00375297Phase 4
- Cognitive Behavioral vs. Interpersonal Therapy (IPT) Prevention of Depression in AdolescentsCompletedNCT00374439Not applicable
- Preventing Depression Recurrence in DiabetesCompletedNCT00374426Phase 4
- Cradling Our Future Through Family Strengthening StudyCompletedNCT00373750Not applicable
- A Study of the Cost Effectiveness of Generalist Care Managers for Depression Treatment in Medicaid RecipientsCompletedNCT00373477Not applicable
- Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal CancerCompletedNCT00373022Not applicable
- Postpartum Depression and Cesarean SectionCompletedNCT00370903
- Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed PatientsCompletedNCT00369798Phase 1
- Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.CompletedNCT00368862Phase 4
- A Local Register Study For Major Depression Of Paroxetine Controlled ReleaseCompletedNCT00368303Phase 3